Communication gaps between patients with breast cancer, caregivers, oncology care team
the ONA take:
Survey results presented at the 37th Annual San Antonio Breast Cancer Symposium reveal that discussions on basic disease information between patients with metastatic breast cancer, their caregivers, and oncologists need improvement.
The “Make your dialogue count” survey was conducted from June 2014 through August 2014. It was developed to gain insight from adult women ages 21 years and older with metastatic breast cancer, adult caregivers of these patients who attend at least half the patients’ clinic visits, and medical oncologists who treat five or more women with metastatic breast cancer per month.
Survey results indicate most patients (83%) and caregivers (76%) are extremely or very involved in treatment decisions; however, many patients and caregivers did not know the HER2 status (20% and 29%, respectively) or the HR status (16% and 30%, respectively).
In addition, 27% of oncologists indicated that they do not discuss the fact that metastatic breast cancer is incurable with patients in certain circumstances.
Most patients (73%) want more information on preventing and minimizing side effects; however, 43% of patients do not always openly discuss side effects with their oncologists. The investigators conclude that improved dialogue can clarify patients’ and caregivers’ expectations about disease management.
Discussions on basic disease information between patients with metastatic breast cancer, caregivers, and oncologists.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|